Abiel srl (Biomedical and Industrial Applications of Lytic Enzymes) is a new biotechnology company founded in 2010 as a spin-off of Palermo University and CNR.
The company's is committed to R&D, production and marketing of innovative and high quality lytic enzymes mainly utilized in the field of tissue dissociation for cell therapy and TERM treatments.
Abiel aims to become an international leader in the discovery, development and marketing of innovative and value-added biotechnological lytic enzymes for TERM, biopharmaceutical and industrial applications.